Molecular mechanisms involved in antibody-dependent enhancement of dengue virus infection in humans.
about
Antibody-Dependent Enhancement of Dengue Virus Infection in Primary Human Macrophages; Balancing Higher Fusion against Antiviral ResponsesVitamin D-Regulated MicroRNAs: Are They Protective Factors against Dengue Virus Infection?Zika in the United States: How Are We Preparing?The Complexity of a Dengue Vaccine: A Review of the Human Antibody ResponseDengue E Protein Domain III-Based DNA Immunisation Induces Strong Antibody Responses to All Four Viral SerotypesNear-Atomic Resolution Cryo-Electron Microscopic Structure of Dengue Serotype 4 VirusThe Antigenic Structure of Zika Virus and Its Relation to Other Flaviviruses: Implications for Infection and ImmunoprophylaxisHistorical Perspectives on Flavivirus ResearchLow copy numbers of DC-SIGN in cell membrane microdomains: implications for structure and function.First experimental in vivo model of enhanced dengue disease severity through maternally acquired heterotypic dengue antibodiesMaternal Antibody-Mediated Disease Enhancement in Type I Interferon-Deficient Mice Leads to Lethal Disease Associated with Liver DamageIgG antibodies to dengue enhanced for FcγRIIIA binding determine disease severity.Anti-Idiotypic Antibodies Specific to prM Monoantibody Prevent Antibody Dependent Enhancement of Dengue Virus Infection.Endocytosis of viruses and bacteria.Elucidating the role of T cells in protection against and pathogenesis of dengue virus infections.Novel recombinant chimeric virus-like particle is immunogenic and protective against both enterovirus 71 and coxsackievirus A16 in mice.Immature dengue virus is infectious in human immature dendritic cells via interaction with the receptor molecule DC-SIGN.Preexisting neutralizing antibody responses distinguish clinically inapparent and apparent dengue virus infections in a Sri Lankan pediatric cohortDengue Virus Infection of Aedes aegypti Requires a Putative Cysteine Rich Venom Protein.Relative Contribution of Dengue IgG Antibodies Acquired during Gestation or Breastfeeding in Mediating Dengue Disease Enhancement and Protection in Type I Interferon Receptor-Deficient MiceValidation and Application of a Commercial Quantitative Real-Time Reverse Transcriptase-PCR Assay in Investigation of a Large Dengue Virus Outbreak in Southern Taiwan.Antibody-dependent enhancement of dengue virus infection inhibits RLR-mediated Type-I IFN-independent signalling through upregulation of cellular autophagy.Mucosal vaccines: novel strategies and applications for the control of pathogens and tumors at mucosal sites.The cytokine response of U937-derived macrophages infected through antibody-dependent enhancement of dengue virus disrupts cell apical-junction complexes and increases vascular permeability.Zika Virus as an Emerging Neuropathogen: Mechanisms of Neurovirulence and Neuro-Immune Interactions.Dengue fever in Europe: could there be an epidemic in the future?A novel dengue virus serotype 1 vaccine candidate based on Japanese encephalitis virus vaccine strain SA14-14-2 as the backbone.Characterization of in vitro dengue virus resistance to carrageenan.A novel mosquito ubiquitin targets viral envelope protein for degradation and reduces virion production during dengue virus infection.The Role and Function of Fcγ Receptors on Myeloid Cells.Use of a Recombinant Gamma-2 Herpesvirus Vaccine Vector against Dengue Virus in Rhesus Monkeys.Beyond attachment: Roles of DC-SIGN in dengue virus infection.Secondary Dengue Virus infections during the 2009 outbreak in Buenos Aires.Increased severity of respiratory infections associated with elevated anti-LPS IgG2 which inhibits serum bactericidal killing.Autoimmune Neurological Conditions Associated With Zika Virus Infection.B cell subset alteration and the expression of tissue homing molecules in dengue infected patientsBlockade of dengue virus entry into myeloid cells by endocytic inhibitors in the presence or absence of antibodies
P2860
Q25708015-222ADDB0-DDAC-43E5-8345-0FEBFC00A7E6Q26746990-B8536E2B-5D31-4731-8B3F-7517A360752FQ26970792-4630C6F4-AF05-4AB3-A0BF-521AA2BF78B8Q26995782-6F123297-DFB7-4985-9AC1-D1350990EAF4Q27304342-88B063DE-35DA-42B3-A3C6-47D20856D6DFQ27680452-E7BF7E67-66E0-4487-AA82-6C19D972190FQ28804225-5F96F23F-4E0F-4AC8-9259-FF871DC7169AQ29994534-ED9431C2-3ABB-4F75-A83B-9E6282A5871BQ30584406-90109FAF-3675-40CB-82B8-A5522F405724Q31156754-0986B0B4-A52E-4086-ACBC-0E6822141F75Q33430984-9DCB3E91-1F33-4FCC-BF51-A8F60DC4FB74Q33438726-9448FFDF-0506-4EA8-919A-7A3C60EF8C2AQ33650118-E1CF279F-EB6D-41D3-9B64-A599407CE66AQ33938568-C9BC9F86-BC48-4827-AB8F-FE8BBACFEA8FQ33959381-E97ED00D-1EDF-417B-AECB-516ECE4A74C6Q34981056-6E18AF1D-7BD2-4FB2-B7CE-5326820D655EQ35179653-E4D1BE9F-BC60-45DF-AC97-30E6C8A95492Q35221318-BFEBD2E4-E005-4337-9A67-A38E1CB3DD15Q35817119-14F27387-DCDA-4D82-BDC9-0BA4736CB80AQ36060983-4F1B77F5-0D84-42BC-910B-CD7B9C8A9223Q36161353-AC942044-5BC7-4F3B-84CF-9D2ABC3917B5Q36628520-30E97F0F-AAA3-4D4A-AB91-F1DE57E6DB42Q36978334-76447E9C-B357-4CE4-BACC-502764962760Q36978907-ABC95F9F-A377-4056-9D2A-A4D0E9B31E71Q38158918-BE7F7A7C-5063-4363-954E-C45C8E564785Q38268430-635EFCE6-5887-4EFA-B7E4-91A6AE1F8511Q38786420-4F6E05FB-A238-4DB8-8B34-277C57A3ABEFQ38809813-60880698-4589-4E38-87BB-FC827DA0AC00Q38860632-C616D89B-4E42-4CFB-BA28-744CF1D59EA7Q39088502-A0C63BFB-0D2E-45D2-8F51-1FCCBB6EB705Q40053434-E766876D-4F7A-4A20-A32C-9D646FCA3545Q40071544-A308BB91-44C2-4609-B136-66F81AE71609Q40135638-3803CAA9-A2F4-420B-A2C3-9DAB08E7AEB2Q40197170-98F798E1-D299-44FE-A1FC-63F9808CEFF8Q55026039-10FA3E66-23DB-43F7-8141-D653AF7D8994Q58701074-CF78FAFA-19CF-433D-858E-D4BDA3F98E5AQ58792953-82EC0817-40CB-43AB-ABA5-12A388E0C036
P2860
Molecular mechanisms involved in antibody-dependent enhancement of dengue virus infection in humans.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Molecular mechanisms involved ...... gue virus infection in humans.
@en
type
label
Molecular mechanisms involved ...... gue virus infection in humans.
@en
prefLabel
Molecular mechanisms involved ...... gue virus infection in humans.
@en
P2860
P356
P1433
P1476
Molecular mechanisms involved ...... gue virus infection in humans.
@en
P2093
Jolanda M Smit
P2860
P356
10.1111/TRA.12012
P577
2012-10-22T00:00:00Z